CTLT - Catalent, Inc Company Value to Earnings Growth Ratio

Brandmark of Catalent, Inc. (CTLT)

Rising demand for obesity drugs is driving the expansion of the CDMO market, as reflected in the price action of Catalent, Inc. (CTLT). The average peg_co level confirms the impact of the $16.5 billion Novo Holdings deal, although the sector's moderate cyclicality creates risks in a high-cost-of-capital environment. Currently, the value is holding at 0.00, helping to determine the asset's degree of undervaluation relative to earnings growth rates.

CTLT Catalent Pharma Solutions Price/Earnings to Growth Ratio (07/04/2022 - 01/04/2025)

Metric breakdowns and analytics for Catalent, Inc. (CTLT)

- share price and consensus valuation forecast:
Price Performance Chart Catalent Inc.|CTLT - Consensus Target
- market capitalization statistics:
Market Value Catalent Pharma Solutions|CTLT - Enterprise Value
- book capitalization information:
Net Asset Value per Share Catalent|CTLT - Company Book Value|Market Capitalization to Book Value catalent.com|CTLT - Cumulative Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Capital Catalent, Inc.|CTLT - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient catalent.com|CTLT - Company Aggregate Debts|Debt to Book Value Catalent Pharma Solutions|CTLT - Company Long-Term Debts|Company Short-Term Debts Catalent|Intermediate Liquidity Ratio catalent.com
- earnings and multiples data:
CTLT - Net Profit|Projected Future Earnings Catalent, Inc.|CTLT - Price to Earnings Ratio|Future Price to Earnings Catalent, Inc|CTLT - PEG Multiple|Company Value to EBITDA Catalent Pharma Solutions|CTLT - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Catalent|CTLT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months catalent.com|CTLT - Net earnings per share growth this year|Expected earnings per share trend next year Catalent, Inc.
General company analysis:CTLT (Catalent Inc.)
Brand item of Catalent

The stability of Catalent, Inc. (CTLT) depends on maximizing the utilization of sterile lines to cover capital expenditures, which is temporarily constrained by restructuring costs. The PEG ratio allows for an assessment of the share price relative to the speed of business expansion, where a value below one signals undervaluation, a fact clearly confirmed by the PEG ratio trend.

Competing companies

IQV (IQVIA Holdings) - Growth-Adjusted Payback Ratio|Laboratory Corporation of America - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio MEDP (Medpace Corp)|ICON plc - PEG Multiple|Price to Earnings Adjusted for Growth Rate criver.com|Evotec (EVO) - Price/Earnings to Growth Ratio|FTRE - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple LFCR|OABI (OmniAb Inc) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Inotiv, Inc. (NOTV)|Growth-Adjusted Market Cap to Net Income avidbio.com|PEG Multiple SCPX (Scorpius Holdings)